{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:43:35Z","timestamp":1757450615228,"version":"3.40.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Biosafety Research Project","award":["20SWAQX23-002-002"],"award-info":[{"award-number":["20SWAQX23-002-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00253-023-12515-2","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T08:13:05Z","timestamp":1681459985000},"page":"3205-3216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs"],"prefix":"10.1007","volume":"107","author":[{"given":"Dan-Yang","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Sheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Yun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Zhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"issue":"3","key":"12515_CR1","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1128\/IAI.01025-07","volume":"76","author":"MR Baldwin","year":"2008","unstructured":"Baldwin MR, Tepp WH, Przedpelski A, Pier CL, Bradshaw M, Johnson EA, Barbieri JT (2008) Subunit vaccine against the seven serotypes of botulism. Infect Immun 76(3):1314\u20131318. https:\/\/doi.org\/10.1128\/IAI.01025-07","journal-title":"Infect Immun"},{"issue":"9","key":"12515_CR2","doi-asserted-by":"publisher","first-page":"e0222670","DOI":"10.1371\/journal.pone.0222670","volume":"14","author":"D Barker","year":"2019","unstructured":"Barker D, Gillum KT, Niemuth NA, Kodihalli S (2019) Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs. PLoS One 14(9):e0222670","journal-title":"PLoS One"},{"doi-asserted-by":"publisher","unstructured":"Ben David A, Barnea A, Torgeman A, Diamant E, Dor E, Schwartz A, Rosen O, Caspi N, Saraf M, Lerer E, Adar Y, Lupo E, Toister E, Zichel R (2022) Immunologic and protective properties of subunit- vs. whole toxoid-derived anti-botulinum equine antitoxin. Vaccines 10(9):1522. https:\/\/doi.org\/10.3390\/vaccines10091522","key":"12515_CR3","DOI":"10.3390\/vaccines10091522"},{"issue":"2","key":"12515_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/DMP.0b013e318158c5fd","volume":"1","author":"ZF Dembek","year":"2007","unstructured":"Dembek ZF, Smith LA, Rusnak JM (2007) Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities. Disaster Med Public Health Prep 1(2):122\u2013134. https:\/\/doi.org\/10.1097\/DMP.0b013e318158c5fd","journal-title":"Disaster Med Public Health Prep"},{"key":"12515_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/164_2019_342","volume":"263","author":"M Dong","year":"2021","unstructured":"Dong M, Stenmark P (2021) The structure and classification of botulinum toxins. Handb Exp Pharmacol 263:11\u201333. https:\/\/doi.org\/10.1007\/164_2019_342","journal-title":"Handb Exp Pharmacol"},{"doi-asserted-by":"publisher","unstructured":"Emanuel A, Qiu H, Barker D, Takla T, Gillum K, Neimuth N, Kodihalli S (2019) Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model. PLoS One 14(1):e0209019. https:\/\/doi.org\/10.1371\/journal.pone.0209019","key":"12515_CR6","DOI":"10.1371\/journal.pone.0209019"},{"key":"12515_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4161\/hv.6.6.11709","volume":"6","author":"YL Gao","year":"2010","unstructured":"Gao YL, Gao S, Kang L, Nie C, Wang JL (2010) Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen. Hum Vaccin 6:462\u2013466. https:\/\/doi.org\/10.4161\/hv.6.6.11709","journal-title":"Hum Vaccin"},{"issue":"3","key":"12515_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1128\/jb.01180-06","volume":"189","author":"KK Hill","year":"2007","unstructured":"Hill KK, Smith TJ, Helma CH, Ticknor LO, Foley BT, Svensson RT, Brown JL, Johnson EA, Smith LA, Okinaka RT, Jackson PJ, Marks JD (2007) Genetic diversity among botulinum neurotoxin-producing clostridial strains. J Bacteriol 189(3):818\u2013832. https:\/\/doi.org\/10.1128\/jb.01180-06","journal-title":"J Bacteriol"},{"issue":"7","key":"12515_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4014\/jmb.1904.04027","volume":"29","author":"NY Kim","year":"2019","unstructured":"Kim NY, Park KE, Lee YJ, Kim YM, Hong SH, Son WR, Hong S, Lee S, Ahn HB, Yang J, Seo JP, Lim YK, Yu CH, Hur GH, Jeong ST, Lee HS, Song K, Kang TJ, Shin YK, Choi JS, Choi JY (2019) Development of an equine antitoxin by immunizing the Halla Horse with the receptor-binding domain of botulinum neurotoxin type A1. J Microbiol Biotechnol 29(7):1165\u20131176. https:\/\/doi.org\/10.4014\/jmb.1904.04027","journal-title":"J Microbiol Biotechnol"},{"issue":"2","key":"12515_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejpb.2011.02.018","volume":"78","author":"S Kittipongwarakarn","year":"2011","unstructured":"Kittipongwarakarn S, Hawe A, Tantipolphan R, Limsuwun K, Khomvilai S, Puttipipatkhachorn S, Jiskoot W (2011) New method to produce equine antirabies immunoglobulin F(ab\u2032)(2) fragments from crude plasma in high quality and yield. Eur J Pharm Biopharm 78(2):189\u2013195. https:\/\/doi.org\/10.1016\/j.ejpb.2011.02.018","journal-title":"Eur J Pharm Biopharm"},{"doi-asserted-by":"publisher","unstructured":"Kodihalli S, Emanuel A, Takla T, Hua Y, Hobbs C, LeClaire R, O\u2019Donnell DC (2017) Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques. PLoS One 12(11):e0186892. https:\/\/doi.org\/10.1371\/journal.pone.0186892","key":"12515_CR11","DOI":"10.1371\/journal.pone.0186892"},{"issue":"4","key":"12515_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.biologicals.2012.03.004","volume":"40","author":"D Li","year":"2012","unstructured":"Li D, Mattoo P, Keller JE (2012) New equine antitoxins to botulinum neurotoxins serotypes A and B. Biologicals 40(4):240\u2013246. https:\/\/doi.org\/10.1016\/j.biologicals.2012.03.004","journal-title":"Biologicals"},{"key":"12515_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/toxins15030200","volume":"15","author":"Z Li","year":"2023","unstructured":"Li Z, Li B, Lu J, Liu X, Tan X, Wang R, Du P, Yu S, Xu Q, Pang X, Yu Y, Yang Z (2023) Biological and immunological characterization of a functional L-HN derivative of botulinum neurotoxin serotype F. Toxins 15:200. https:\/\/doi.org\/10.3390\/toxins15030200","journal-title":"Toxins"},{"issue":"2","key":"12515_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/toxins14020135","volume":"14","author":"Z Li","year":"2022","unstructured":"Li Z, Lu J, Tan X, Wang R, Xu Q, Yu Y, Yang Z (2022) Functional EL-HN Fragment as a potent candidate vaccine for the prevention of botulinum neurotoxin serotype E. Toxins 14(2):135. https:\/\/doi.org\/10.3390\/toxins14020135","journal-title":"Toxins"},{"key":"12515_CR15","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s12640-021-00337-x","volume":"39","author":"Z Li","year":"2021","unstructured":"Li Z, Lu JS, Liu S, Wang R, Xu Q, Yu YZ, Yang ZX (2021) Recombinant L-HN fusion antigen derived from the L and HN domains of botulinum Neurotoxin B stimulates a protective antibody response against active neurotoxin. Neurotox Res 39:1044\u20131053. https:\/\/doi.org\/10.1007\/s12640-021-00337-x","journal-title":"Neurotox Res"},{"key":"12515_CR16","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.1038\/srep07678","volume":"5","author":"B Liu","year":"2015","unstructured":"Liu B, Shi D, Chang S, Gong X, Yu Y, Sun Z, Wu J (2015) Characterization and immunological activity of different forms of recombinant secreted Hc of botulinum neurotoxin serotype B products expressed in yeast. Sci Rep 5:7678. https:\/\/doi.org\/10.1038\/srep07678","journal-title":"Sci Rep"},{"issue":"14","key":"12515_CR17","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1016\/j.vaccine.2020.02.060","volume":"38","author":"FJ Liu","year":"2020","unstructured":"Liu FJ, Shi DY, Mao YY, Xiong XH, Lu JS, Pang XB, Dong XJ, Yang ZX, Yu YZ (2020) Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A. Vaccine 38(14):2978\u20132983. https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.060","journal-title":"Vaccine"},{"issue":"8","key":"12515_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/toxins12080509","volume":"12","author":"D Lonati","year":"2020","unstructured":"Lonati D, Schicchi A, Crevani M, Buscaglia E, Scaravaggi G, Maida F, Cirronis M, Petrolini VM, Locatelli CA (2020) Foodborne botulism: clinical diagnosis and medical treatment. Toxins 12(8):509. https:\/\/doi.org\/10.3390\/toxins12080509","journal-title":"Toxins"},{"key":"12515_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpeds.2017.12.002","volume":"193","author":"SS Long","year":"2018","unstructured":"Long SS (2018) BabyBIG has BIG advantages for treatment of infant botulism. J Pediatr 193:1. https:\/\/doi.org\/10.1016\/j.jpeds.2017.12.002","journal-title":"J Pediatr"},{"key":"12515_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.anaerobe.2014.06.003","volume":"28","author":"G Moreira","year":"2014","unstructured":"Moreira G, Cunha C, Salvarani F, Gon\u00e7alves L, Pires P, Concei\u00e7\u00e3o F, Lobato F (2014) Production of recombinant botulism antigens: a review of expression systems. Anaerobe 28:130\u2013136. https:\/\/doi.org\/10.1016\/j.anaerobe.2014.06.003","journal-title":"Anaerobe"},{"issue":"8","key":"12515_CR21","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.toxicon.2005.08.006","volume":"46","author":"V Morais","year":"2005","unstructured":"Morais V, Massaldi H (2005) Effect of pepsin digestion on the antivenom activity of equine immunoglobulins. Toxicon 46(8):876\u2013882. https:\/\/doi.org\/10.1016\/j.toxicon.2005.08.006","journal-title":"Toxicon"},{"key":"12515_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuropharm.2018.06.016","volume":"138","author":"M Nugent","year":"2018","unstructured":"Nugent M, Yusef YR, Meng J, Wang J, Dolly JO (2018) A SNAP-25 cleaving chimera of botulinum neurotoxin \/A and \/E prevents TNF\u03b1-induced elevation of the activities of native TRP channels on early postnatal rat dorsal root ganglion neurons. Neuropharmacology 138:257\u2013266. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.06.016","journal-title":"Neuropharmacology"},{"doi-asserted-by":"publisher","unstructured":"O'Horo JC, Harper EP, El Rafei A, Ali R, DeSimone DC, Sakusic A, Abu Saleh OM, Marcelin JR, Tan EM, Rao AK, Sobel J, Tosh PK (2017) Efficacy of antitoxin therapy in treating patients with foodborne botulism: a systematic review and Meta-analysis of cases, 1923\u20132016. Clin Infect Dis 66(suppl_1):S43-S56 https:\/\/doi.org\/10.1093\/cid\/cix815","key":"12515_CR23","DOI":"10.1093\/cid\/cix815"},{"issue":"1","key":"12515_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/toxins14010019","volume":"14","author":"GS Parrera","year":"2021","unstructured":"Parrera GS, Astacio H, Tunga P, Anderson DM, Hall CL, Richardson JS (2021) Use of botulism antitoxin heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT(\u00ae)) in clinical study subjects and patients: A 15-Year systematic safety review. Toxins 14(1):19. https:\/\/doi.org\/10.3390\/toxins14010019","journal-title":"Toxins"},{"issue":"2","key":"12515_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1124\/pr.116.012658","volume":"69","author":"M Pirazzini","year":"2017","unstructured":"Pirazzini M, Rossetto O, Eleopra R, Montecucco C (2017) Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev 69(2):200. https:\/\/doi.org\/10.1124\/pr.116.012658","journal-title":"Pharmacol Rev"},{"doi-asserted-by":"publisher","unstructured":"Raja SM, Guptill JT, Juel VC, Walter EB, Cohen-Wolkowiez M, Hill H, Sendra E, Hauser B, Jackson P, Tomic M, Espinoza Y, Swamy GK (2022) First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of single doses of NTM-1633, a novel mixture of monoclonal antibodies against botulinum toxin E. Antimicrob Agents Chemother 66(4):e0173221. https:\/\/doi.org\/10.1128\/aac.01732-21","key":"12515_CR26","DOI":"10.1128\/aac.01732-21"},{"doi-asserted-by":"publisher","unstructured":"Rao AK, Sobel J, Chatham-Stephens K, Luquez C (2021) Clinical guidelines for diagnosis and treatment of botulism, 2021. MMWR Recomm Rep 70(2):1\u201330. https:\/\/doi.org\/10.15585\/mmwr.rr7002a1","key":"12515_CR27","DOI":"10.15585\/mmwr.rr7002a1"},{"doi-asserted-by":"publisher","unstructured":"Rasetti-Escargueil C, Avril A, Miethe S, Mazuet C, Derman Y, Selby K, Thullier P, Pelat T, Urbain R, Fontayne A, Korkeala H, Sesardic D, Hust M, Popoff MR (2017) The European antibotABE framework program and its update: development of innovative botulinum antibodies.Toxins (Basel) 9(10):309. https:\/\/doi.org\/10.3390\/toxins9100309","key":"12515_CR28","DOI":"10.3390\/toxins9100309"},{"issue":"9","key":"12515_CR29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/toxins11090528","volume":"11","author":"C Rasetti-Escargueil","year":"2019","unstructured":"Rasetti-Escargueil C, Popoff MR (2019) Antibodies and vaccines against botulinum toxins: available measures and novel approaches. Toxins 11(9):528. https:\/\/doi.org\/10.3390\/toxins11090528","journal-title":"Toxins"},{"issue":"4","key":"12515_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.toxicon.2006.07.004","volume":"48","author":"A Rial","year":"2006","unstructured":"Rial A, Morais V, Rossi S, Massaldi H (2006) A new ELISA for determination of potency in snake antivenoms. Toxicon 48(4):462\u2013466. https:\/\/doi.org\/10.1016\/j.toxicon.2006.07.004","journal-title":"Toxicon"},{"issue":"9","key":"12515_CR31","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/cid\/ciz515","volume":"70","author":"JS Richardson","year":"2020","unstructured":"Richardson JS, Parrera GS, Astacio H, Sahota H, Anderson DM, Hall C, Babinchak T (2020) Safety and clinical outcomes of an equine-derived heptavalent botulinum antitoxin treatment for confirmed or suspected botulism in the United States. Clin Infect Dis 70(9):1950\u20131957. https:\/\/doi.org\/10.1093\/cid\/ciz515","journal-title":"Clin Infect Dis"},{"issue":"5","key":"12515_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.pediatrneurol.2015.01.006","volume":"52","author":"LK Rosow","year":"2015","unstructured":"Rosow LK, Strober JB (2015) Infant botulism: review and clinical update. Pediatr Neurol 52(5):487\u2013492. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.01.006","journal-title":"Pediatr Neurol"},{"key":"12515_CR33","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/toxins11120686","volume":"11","author":"O Rossetto","year":"2019","unstructured":"Rossetto O, Montecucco C (2019) Tables of toxicity of botulinum and tetanus neurotoxins. Toxins 11:686. https:\/\/doi.org\/10.3390\/toxins11120686","journal-title":"Toxins"},{"issue":"45","key":"12515_CR34","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.1016\/j.vaccine.2010.08.076","volume":"28","author":"JD Shearer","year":"2010","unstructured":"Shearer JD, Vassar ML, Swiderski W, Metcalfe K, Niemuth N, Henderson I (2010) Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A\/B). Vaccine 28(45):7313\u20137318. https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.076","journal-title":"Vaccine"},{"doi-asserted-by":"publisher","unstructured":"Shi DY, Chen BY, Mao YY, Zhou G, Lu JS, Yu YZ, Zhou XW, Sun ZW (2019) Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B. Hum Vaccin Immunother 15(3):755\u2013760 https:\/\/doi.org\/10.1080\/21645515.2018.1547613","key":"12515_CR35","DOI":"10.1080\/21645515.2018.1547613"},{"doi-asserted-by":"publisher","unstructured":"Shi DY, Liu FJ, Li ZY, Mao YY, Lu JS, Wang R, Pang XB, Yu YZ, Yang ZX (2022) Development and evaluation of a tetravalent botulinum vaccine. Hum Vaccin Immunother 18(5):2048621 https:\/\/doi.org\/10.1080\/21645515.2022.2048621","key":"12515_CR36","DOI":"10.1080\/21645515.2022.2048621"},{"doi-asserted-by":"publisher","unstructured":"Shi DY, Liu FJ, Mao YY, Cui RT, Lu JS, Yu YZ, Dong XJ, Yang ZX, Sun ZW, Pang XB (2020) Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E. Hum Vaccin Immunother 16(1):100\u2013108 https:\/\/doi.org\/10.1080\/21645515.2019.1633878","key":"12515_CR37","DOI":"10.1080\/21645515.2019.1633878"},{"issue":"1","key":"12515_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/10408410590912952","volume":"31","author":"HD Shukla","year":"2005","unstructured":"Shukla HD, Sharma SK (2005) Clostridium botulinum: a bug with beauty and weapon. Crit Rev Microbiol 31(1):11\u201318. https:\/\/doi.org\/10.1080\/10408410590912952","journal-title":"Crit Rev Microbiol"},{"issue":"3","key":"12515_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jbiotec.2006.07.022","volume":"127","author":"J Sinha","year":"2007","unstructured":"Sinha J, Inan M, Fanders S, Taoka S, Gouthro M, Swanson T, Barent R, Barthuli A, Loveless BM, Smith LA, Smith T, Henderson I, Ross J, Meagher MM (2007) Cell bank characterization and fermentation optimization for production of recombinant heavy chain C-terminal fragment of botulinum neurotoxin serotype E (rBoNTE(Hc): Antigen E) by Pichia pastoris. J Biotechnol 127(3):462\u2013474. https:\/\/doi.org\/10.1016\/j.jbiotec.2006.07.022","journal-title":"J Biotechnol"},{"doi-asserted-by":"publisher","unstructured":"Smith LA (2009) Botulism and vaccines for its prevention. Vaccine 27 Suppl 4(47):D33-D9 https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.059","key":"12515_CR40","DOI":"10.1016\/j.vaccine.2009.08.059"},{"issue":"8","key":"12515_CR41","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1086\/444507","volume":"41","author":"J Sobel","year":"2005","unstructured":"Sobel J (2005) Botulism. Clin Infect Dis 41(8):1167\u20131173. https:\/\/doi.org\/10.1086\/444507","journal-title":"Clin Infect Dis"},{"doi-asserted-by":"publisher","unstructured":"Tehran DA, Pirazzini M (2018) Novel botulinum neurotoxins: exploring underneath the iceberg tip. Toxins 10(5) https:\/\/doi.org\/10.3390\/toxins10050190","key":"12515_CR42","DOI":"10.3390\/toxins10050190"},{"issue":"9","key":"12515_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/toxins13090671","volume":"13","author":"MT Tomic","year":"2021","unstructured":"Tomic MT, Farr-Jones S, Syar ES, Niemuth N, Kobs D, Hackett MJ, Espinoza Y, Martinez Z, Pham K, Snow DM, Marks JD, Cobb RR (2021) Neutralizing concentrations of anti-botulinum toxin antibodies positively correlate with mouse neutralization assay results in a guinea pig model. Toxins (basel) 13(9):671. https:\/\/doi.org\/10.3390\/toxins13090671","journal-title":"Toxins (basel)"},{"issue":"25","key":"12515_CR44","doi-asserted-by":"publisher","first-page":"16993","DOI":"10.1074\/jbc.M710442200","volume":"283","author":"J Wang","year":"2008","unstructured":"Wang J, Meng J, Lawrence GW, Zurawski TH, Sasse A, Bodeker MO, Gilmore MA, Fern\u00e1ndez-Salas E, Francis J, Steward LE, Aoki KR, Dolly JO (2008) Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics. J Biol Chem 283(25):16993\u201317002. https:\/\/doi.org\/10.1074\/jbc.M710442200","journal-title":"J Biol Chem"},{"issue":"5","key":"12515_CR45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/135965350501000504","volume":"10","author":"X Wang","year":"2005","unstructured":"Wang X, Ni B, Du X, Zhao G, Gao W, Shi X, Zhang S, Zhang L, Wang D, Luo D, Xing L, Jiang H, Li W, Jiang M, Mao L, He Y, Xiao Y, Wu Y (2005) Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody. Antivir Ther 10(5):681\u2013690","journal-title":"Antivir Ther"},{"issue":"9","key":"12515_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/toxins9090269","volume":"9","author":"RP Webb","year":"2017","unstructured":"Webb RP, Smith TJ, Smith LA, Wright PM, Guernieri RL, Brown JL, Skerry JC (2017) Recombinant botulinum neurotoxin Hc subunit (BoNT Hc) and catalytically inactive Clostridium botulinum holoproteins (ciBoNT HPs) as vaccine candidates for the prevention of botulism. Toxins (basel) 9(9):269. https:\/\/doi.org\/10.3390\/toxins9090269","journal-title":"Toxins (basel)"},{"doi-asserted-by":"publisher","unstructured":"Yu PA, Lin NH, Mahon BE, Sobel J, Yu Y, Mody RK, Gu W, Clements J, Kim HJ, Rao AK (2017) Safety and improved clinical outcomes in patients treated with new equine-derived heptavalent botulinum antitoxin. Clin Infect Dis 66(suppl_1):S57-S64 https:\/\/doi.org\/10.1093\/cid\/cix816","key":"12515_CR47","DOI":"10.1093\/cid\/cix816"},{"issue":"2","key":"12515_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.clim.2010.07.005","volume":"137","author":"YZ Yu","year":"2010","unstructured":"Yu YZ, Zhang SM, Ma Y, Zhu HQ, Wang WB, Du Y, Zhou XW, Wang RL, Wang S, Yu WY, Huang PT, Sun ZW (2010a) Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F. Clin Immunol 137(2):271\u2013280. https:\/\/doi.org\/10.1016\/j.clim.2010.07.005","journal-title":"Clin Immunol"},{"issue":"10","key":"12515_CR49","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.biochi.2010.06.010","volume":"92","author":"YZ Yu","year":"2010","unstructured":"Yu YZ, Zhang SM, Wang WB, Du Y, Zhu HQ, Wang RL, Zhou XW, Lin JB, Wang S, Yu WY (2010b) Development and preclinical evaluation of a new F(ab\u2032)2 antitoxin against botulinum neurotoxin serotype A. Biochimie 92(10):1315\u20131320. https:\/\/doi.org\/10.1016\/j.biochi.2010.06.010","journal-title":"Biochimie"},{"issue":"10","key":"12515_CR50","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.biochi.2010.06.010","volume":"92","author":"YZ Yu","year":"2010","unstructured":"Yu YZ, Zhang SM, Wang WB, Du Y, Zhu HQ, Wang RL, Zhou XW, Lin JB, Wang S, Yu WY, Huang PT, Sun ZW (2010c) Development and preclinical evaluation of a new F(ab\u2032)2 antitoxin against botulinum neurotoxin serotype A. Biochimie 92(10):1315\u20131320. https:\/\/doi.org\/10.1016\/j.biochi.2010.06.010","journal-title":"Biochimie"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12515-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-023-12515-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12515-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:34:19Z","timestamp":1744212859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-023-12515-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["12515"],"URL":"https:\/\/doi.org\/10.1007\/s00253-023-12515-2","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"type":"print","value":"0175-7598"},{"type":"electronic","value":"1432-0614"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"assertion":[{"value":"26 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Animal Care and Use Committee of the Beijing Institute of Biotechnology approved all the animal experiments, which were carried out following the institute\u2019s ethical guidelines and the National Institutes of Health guide for the care and use of laboratory animals (IACUC-DWZX-2019\u2013017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}